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Abstract
Antimicrobial resistance is an important public health concern that has implications in the practice of
medicine worldwide. Accurately predicting resistance phenotypes from genome sequences shows
great promise in promoting better use of antimicrobial agents, by determining which antibiotics
are likely to be effective in specific clinical cases. In healthcare, this would allow for the design
of treatment plans tailored for specific individuals, likely resulting in better clinical outcomes for
patients with bacterial infections. In this work, we present the recent work of Drouin et al. (2016)
on using Set Covering Machines to learn highly interpretable models of antibiotic resistance and
complement it by providing a large scale application of their method to the entire PATRIC database.
We report prediction results for 36 new datasets and present the Kover AMR platform, a new web-
based tool allowing the visualization and interpretation of the generated models.
1 Introduction
Modern medicine relies on antimicrobial drugs to treat infections. However, bacteria have evolved mechanisms to
protect themselves from antibiotics [26, 19]. Thus, the use and abuse of antibiotics has lead to the selection and to
the spread of antibiotic-resistant pathogens. In order to define the right treatment and to reduce clinical failures, the
prediction of antimicrobial resistance (AMR) is essential in choosing the right drugs to treat a specific patient [12].
In clinical laboratories, AMR is measured using antibiograms. This method determines the minimal inhibitory con-
centration (MIC) of an antibiotic by measuring the growth of the infecting microorganism in presence of different
concentrations of the drug. The overall objective of this method is to determine if the pathogen will respond to treat-
ment. Clinicians do so by comparing the measured MIC to the guidelines from CLSI or EUCAST, which are constantly
being reevaluated by international committees [14]. However, while susceptibility to antibiotics can be predicted us-
ing MIC, it does not always hold true, as susceptible isolates can sometimes become phenotypically resistant given
the proper conditions [17]. In this case, genomic determinants of resistance can be effective in predicting clinically
relevant antimicrobial resistance [18]. In addition, determination of the MIC requires the growth of microorganisms,
which generally necessitates one to two days of in vitro culture, and even more in the case of slow-growing organisms,
such as Mycobacterium tuberculosis [28]. Genomic methods, such as polymerase chain reaction or whole genome
sequencing, can now be used to predict the resistance phenotypes of pathogens in a more rapid manner [20].
Reanalysis of publicly available genome databases for which AMR phenotypes are available is a useful starting point
to improve our understanding of the relationship between genotype and phenotype. Indeed, several groups have used
machine learning and statistics to understand and predict antimicrobial resistance ([2, 11, 22, 10, 9]). However, models
that predict AMR should not be static and should improve as new genomes are added to databases. For instance,
the Pathosystems Resource Integration Center (PATRIC) database is a large-scale aggregation platform for bacterial
genomes and their associated metadata [27, 22]. The number of genomes in the PATRIC database nearly doubled
between 2014 and 2015, with now more than 52 thousand microbial genome sequences. Recently, Drouin et al.
(2016) proposed to use the Set Covering Machine [16] to learn extremely sparse models of antimicrobial resistance that
are intelligible for domain experts [10]. They compared their models to more complex predictors, such as linear and
kernel-based Support Vector Machines [7, 23, 24], as well as decision trees [3], and showed that Set Covering Machines
achieved comparable, often superior, generalization performance, while being significantly sparser. Moreover, they
demonstrated that highly accurate models of AMR could be obtained, despite features spaces tens of thousands of
times larger than the number of learning examples.
†Corresponding author: alexandre.drouin.8@ulaval.ca
Peer-reviewed and accepted for presentation at the Machine Learning for Health Workshop, NIPS 2016, Barcelona, Spain.
1
ar
X
iv
:1
61
2.
01
03
0v
1 
 [q
-b
io.
GN
]  
3 D
ec
 20
16
The present work summarizes the work of Drouin et al. (2016) and presents extensive new results. Specifically,
we present a large scale application of their method to prospectively generate predictive models of AMR from
the ever-growing collection of genomes in the PATRIC database. Moreover, we present the Kover AMR Platform
(https://aldro61.github.io/kover-amr-platform/), a web-based tool that catalogs AMR prediction results for a wide va-
riety of species and antibiotics, providing detailed metrics and allowing the visualization of the generated models. This
initiative will allow the interpretation of our results by healthcare researchers, generating new research and treatment
opportunities.
2 Methods
2.1 Problem statement
We address the problem of predicting antimicrobial resistance as a supervised learning problem. The goal is to learn a
model that accurately discriminates genomes that are resistant or susceptible to an antibiotic based on genomic char-
acteristics. Formally, we assume that we are given a dataset S def= {(xi, yi)}mi=1 ∼ Dm, where xi ∈ {A,C,G, T}∗
is a bacterial genome, yi ∈ {0, 1} is its associated phenotype (0 for susceptible and 1 for resistant) and D is an
unknown data generating distribution from which the dataset is sampled. We start by defining an alternative represen-
tation for the genomic sequences, where each genome is characterized by the presence or absence of every possible
k-mer, i.e. every possible sequence of k DNA nucleotides. This representation is obtained through a mapping function
φ : {A,C,G, T}∗ → {0, 1}4k , such that φj(x) def= 1 if the k-mer kj is in the genome x and 0 otherwise. This yield the
transformed dataset S′ def= {(φ(xi), yi)}mi=1, which is then used to train the learning algorithm.
The goal is then to find a model h that has a good generalization performance, i.e. that minimizes the probability R(h)
of making a prediction error for any example drawn according to distribution D, i.e.,
R(h)
def
= Pr
(x,y)∼D
[h(φ(x)) 6= y]. (1)
Furthermore, we seek highly interpretable models from which biologically relevant knowledge can be extracted.
2.2 The Set Covering Machine
Such interpretable models are obtained through the Set Covering Machine algorithm (SCM) [16, 10], which produces
models that are logical combinations (conjunctions or disjunctions) of boolean-valued rules that are generated from
the data. We now briefly present the algorithm and direct the reader to [10, 16] for further explanations.
The input of the SCM algorithm is a set of learning examples S and a set of boolean-valued rulesR. In our context, S
is composed of genomes, in the k-mer form induced byφ, and their labels. LetK be the set of all, possibly overlapping,
k-mers that are present in at least one genome of S. For each k-mer kj ∈ K, we consider a presence rule, defined
as pkj (φ(x))
def
= I[φj(x) = 1] and an absence rule, defined as akj (φ(x))
def
= I[φj(x) = 0], where I[true] = 1 and
0 otherwise. These boolean-valued rules constitute the set R. Given S and R, the SCM attempts to find the model
that relies on the smallest possible set of rules R? = {r?1 , ..., r?n} ⊆ R, while minimizing Equation (1). The models
generated can be conjunctions h(φ(x)) def= r?1(φ(x))∧...∧r?n(φ(x)) or disjunctions h(φ(x)) def= r?1(φ(x))∨...∨r?n(φ(x)).
Hence, they directly highlight the importance of a small set of genomic sequences for predicting AMR phenotypes.
However, it is important to note that the distribution D is unknown; therefore, it is not possible to directly minimize
Equation (1). Instead, the algorithm constructs a model that achieves an appropriate trade-off between the empirical
risk (i.e., the fraction of training errors) and the number of rules it uses. A model containing many rules is likely
to overfit the data, whereas a model containing too few rules is likely to underfit. To find the appropriate trade-off
between the classifier’s size and its accuracy on the training set, the SCM relies on a modified version of the set
covering greedy algorithm of Chva´tal [6], which has a worst-case guarantee. The running time and space complexities
of this algorithm are linear in the number of examples and rules, thus linear in the number of genomes and k-mers.
Consequently, this algorithm is particularly well-suited for learning from large datasets of extreme dimensionalities,
such as the ones that often occur in healthcare applications.
The experiments in this work were performed using Kover, the SCM implementation of Drouin et al. (2016), which
has been tailored for learning from k-mer represented genomes [10]. In Kover, the SCM algorithm is trained out-of-
core, which means that the data resides on the disk and is accessed in blocks by the algorithm. The implementation
exploits a compressed data representation and atomic CPU instructions to speed up computations. It is open-source
and available at https://github.com/aldro61/kover.
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Figure 1: Each point corresponds to a dataset. Colored symbols identify bacterial species. a) Size of the datasets in
terms of genomes and k-mers; b) Specificity of the models with respect to their sensitivity; c) Accuracy of the models
with respect to the baseline predictor (see text for details); d) Accuracy of the models with respect to the number of
genomes; e) Accuracy of the models with respect to the number of k-mers; f) Time required to train the algorithm
with respect to the number of genomes.
2.3 Data acquisition
The data used in this study were extracted from the PATRIC database via its FTP server (ftp.patricbrc.org). First, the
latest AMR metadata were acquired. These data consisted of genome identifiers and measured resistance phenotypes
(resistant or susceptible) for various antibiotics. The data were segmented by species and antibiotic to form datasets,
and those with at least 50 genomes in each class were retained. Finally, for each dataset, the assembled genomes were
downloaded and their k-mer representation was obtained using the DSK k-mer counter [21]. The value of k was set
to 31, since extensive experimentation has shown that this value is appropriate for the task at hand [10].
3 Results and discussion
A total of 36 datasets, comprising five bacterial species, were extracted from PATRIC. A detailed list is available in
Appendix - Table 1. Figure 1a shows the size of these datasets, in which the number of examples ranged from 161 to
5022 and the number of k-mers from 4.6 to 43.1 millions. For most species, an increase in the number of genomes
does not lead to a large increase in the number of k-mers. This reflects the limited genomic diversity that exists within
species (e.g.: M. tuberculosis [13]). Contrasting results were observed for P. aeruginosa and A. baumannii, which
have higher genomic diversities [15, 25].
The SCM’s ability to predict AMR phenotypes was evaluated on held-out subsets of the data. First, each dataset was
randomly partitioned into a training set S (80%) and a testing set T (20%). The SCMwas then trained on S and metrics
were computed based on the model’s predictions on T . This procedure was repeated 10 times, on different partitions,
3
- r representation was obtained using the DSK k-mer counter [21]. The value of k was set to
31, since extensive experimentation has shown that this value is appropriate for the task at hand [10].
t t l f t t , ri i fi t ri l i , r tr t fr I . t il li t i il l i
i - l . i r t i f t t t , i i t r f l r fr t
t r f - r fr . t . illi . r t i , i r i t r f
t l t l r i r i t r f - r . i r fl t t li it i i r it t t i t it i
i ( . .: . t l i [ ]). tr ti r lt r r f r . i . ii, i
i r i i r iti [ , ].
’ ilit t r i t t l t l - t t f t t . ir t, t t
r l rtiti i t tr i i t ( ) t ti t ( ). t tr i tri
r t t l’ r i ti . i r r r t ti , iff r t rtiti ,
and the resulting metrics were averaged. The values of the algorithm’s hyperparameters1 (HPs) were selected by
bound selection (see [16, 10]). Bound selection uses a probabilistic upper bound on Equation (1), computed from
the training data, to score each of the HP combinations. For each of the latter, a single training of the algorithm is
required; hence, bound selection is much faster than standard cross-validation. Drouin et al (2016). proposed such
a bound for conjunctions/disjunctions of presence/absence rules of k-mers and found that bound selection yielded
results comparable to those of 5-fold cross-validation.
The results are summarized in Figure 1b-e and detailed in Appendix - Table 2. Figure 1b shows the specificity of the
models with respect to their sensitivity. A perfect model would score 1 for each of these metrics. Specificities superior
to 80% were achieved for 33/36 datasets and comparable sensitivities were achieved for 25/36 datasets. In general,
the obtained models are more specific than sensitive, meaning that they sometimes fail to identify resistant isolates,
but very rarely mark a susceptible isolate as resistant. Figure 1c compares the SCM models to a baseline predictor that
predicts the most abundant class in the training data. The SCM models, which achieve accuracies greater than 80%
on 33/36 datasets, generally surpass the baseline predictors, indicating that the algorithm extracts relevant patterns of
antibiotic resistance. Of note, the models learned by the SCM are extremely sparse, using an average of 2.5 rules (std:
2.2), which makes them well-suited for further review and experimental validation. Moreover, Figure 1c highlights
the strong class imbalance that exists in some of the datasets considered, as the baseline predictors often achieve high
accuracies. Furthermore, based on Figure 1d, we observe that the accuracy of the models is generally higher for
datasets that contain more examples. There are notable exceptions, such as S. pneumoniae, where the accuracies are
lower for larger datasets. However, the two largest datasets for this species correspond to combinations of drugs (Beta-
lactams and Trimethoprim/Sulfamethoxazole), which could complexify the learning task. Also, notice that there are
cases where the algorithm achieves near perfect accuracies with very few examples, despite disproportionately large
feature spaces. In fact, Figure 1e illustrates that the accuracy of the models is not related to the number of k-mers.
This supports the theoretical and empirical results of Drouin et al. (2016), which found that the SCM could avoid
overfitting, even in such high dimensional settings. Finally, Figure 1f shows the time required to train the algorithm
with respect to the number of genomes in each dataset. The time, which grows linearly with the number of genomes,
varied between 8 seconds and 18 minutes, using a single CPU core and less than 1 GB of memory.
The models generated using the SCM are available through the Kover AMR Platform. The k-mer sequences of the
rules in these models were annotated using BLAST [1]. This revealed that, for most antibiotics, the SCM was accurate
in identifying known resistance mechanisms. For example, the absence of one k-mer located in the DNA gyrase
subunit A (gyrA) predicts resistance to moxifloxacin in M. tuberculosis with an error rate as low as 4%. This k-
mer refers to the amino-acids 88 to 94 of GyrA, the mutation of which confers resistance to fluoroquinolones [5].
Thus, the model relies on the absence of the susceptible genotype to account for the presence of resistant variants,
which are more diverse. This behavior was also observed for predicting resistance to isoniazid in M. tuberculosis,
where the model rightly targets a region of the katG gene where multiple mutations are known to induce resistance [4,
8]. The model also relies on a k-mer in the rpoB gene, a known rifampicin resistance determinant [8]. This could result
from the frequent combined use of antituberculosis drugs.
We have briefly demonstrated the accuracy and interpretability of models produced by the SCM. Detailed results are
available in the Appendix and the Kover AMR platform, which allows the visualization and further investigation of
AMR models generated at an unprecedented scale.
4 Conclusion
In summary, we have outlined the recently published work of Drouin et al. (2016), while complementing their analysis
with a large-scale application of their method to the ever-growing PATRIC database. Kover, an extremely efficient out-
of-core implementation of the SCM, allowed the rapid generation of these results with limited computational resources.
Moreover, our results show that the method yields accurate results for predicting AMR in most datasets and that, due
to their strong interpretability, the obtained models can generate biologically relevant insight into these phenotypes.
On another hand, contrasting results were obtained, which pave the way to extensions of their method. In fact, the
obtained models were generally highly specific, but some lacked sensitivity. This could result from seeking the sparsest
model that detects resistant genomes in the entire population of isolates. Hence, the deconvolution of resistance
mechanisms based on population structure could provide a deeper understanding of antibiotic resistance and increase
the sensitivity of the models. Future work will therefore involve the development of algorithmic extensions to the
Set Covering Machine, which allow the inclusion of prior knowledge of the population structure and the biological
structures present in the data (e.g., gene functions, pathways).
1
p ∈ {0.1, 0.178, 0.316, 0.562, 1, 1.778, 3.162, 5.623, 10,+∞}, s ∈ {1, ..., 10}, model type ∈ {conjunction, disjunction} (notation of [10])
4
We have only scratched the surface of the biological knowledge that can be generated from these results.
The fact that our approach generates interpretable predictors, together with our proposed Kover AMR Platform
(https://aldro61.github.io/kover-amr-platform/) will allow further analysis of these results by researchers with diverse
backgrounds, bridging the gap between machine learning and healthcare research.
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